Magdalena Sobieszczyk, MD
Enriched profileChief, Division of Infectious Diseases · Columbia University Irving Medical Center
Magdalena Sobieszczyk is Chief, Division of Infectious Diseases at Columbia University Irving Medical Center. OpenAlex indexes 215 publications with 14,998 citations (h-index 44); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the FindMyKOL directory.
Data verified 22 Oct 2026
Overview
Updated 25 Oct 2026
Magdalena Sobieszczyk, M.D., is Chief, Division of Infectious Diseases at Columbia University Irving Medical Center. The public record shows 215 publications with 14,998 citations (h-index 44), centered on HIV/AIDS Research and Interventions, HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 1 companies, 4 NIH-funded awards (2018–2026).
- Most recent indexed publication: 2026 · bioRxiv
- Top research focus: HIV/AIDS Research and Interventions
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 102.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Menopausal HT for Women Living With HIV (HoT)
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Stick2PrEP Cisgender Women and Trans Individuals
Sponsor: Columbia University
Industry payments
Updated 25 Oct 2026
1 company reported payments to CMS in program years 2023–2023. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Serotonin-1b and Serotonin-1d Receptor Agonist100%Sumatriptan Succinate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 25 Oct 2026
4 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Columbia University-Weill Cornell Medicine CFAR (CU-WCM CFAR)
Columbia University Health Sciences
FY2026$2,499,846P30AI191337 - Columbia Collaborative HIV/AIDS Clinical Trials Unit
Columbia University Health Sciences
FY2026$2,096,920UM1AI069470 - Vagelos College of Physicians & Surgeons Next Generation Physician-Scientist Training Pathway (VP&S-Next Gen PSTP) Program in Infectious Diseases and Immunology
Columbia University Health Sciences
FY2026$619,489R38AI201697
Publications
Updated 25 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Overlapping Clinical Presentation of Long COVID and Postacute COVID-19 Vaccination Syndrome: Phenotypes, Severity, and Biomarkers.
Clinical infectious diseases
Article2026 - Increased Depression and Anxiety Among Men and Transgender Women Receiving Care at a Sexual Health Clinic in New York City During COVID-19.
Open forum infectious diseases
Article2025 - Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.
Science translational medicine
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Article2,311 citations2021
- 02Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19Article1,626 citations2020
- 03Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2Article1,286 citations2021
- 04Antibody evasion properties of SARS-CoV-2 Omicron sublineagesArticle811 citations2022
- 05Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5Article808 citations2022
Network
Updated 25 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 25 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/magdalena-sobieszczyk-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
acp.cuimc.columbia.edu/profile/magdalena-e-sobieszczyk-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acp.cuimc.columbia.edu ↗ - Other
doctors.columbia.edu/us/ny/new-york/magdalena-e-sobieszczyk-md-mph-180-fort-washington-avenue
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
MPH
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acp.cuimc.columbia.edu ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acp.cuimc.columbia.edu ↗
Secondary affiliations
appointments beyond the home institution- Harold C. Neu Professor of Infectious Diseases (in Medicine)
Columbia University Irving Medical Center
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗ - Associate Fellowship Program Director
Infectious Diseases, Columbia University Irving Medical Center
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acp.cuimc.columbia.edu ↗ - Principal investigator
Columbia HVTN and ACTG Clinical Research Site
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hivcenternyc.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iasusa.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
Lawrence Honig, MD
Columbia University Irving Medical Center
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine